Company

Mitoimmune Therapeutics Inc.

Biotechnology Research Seoul, Seoul-teukbyeolsi, Kr 6 employees

Employees: 6
Contacts: 2
Emails: 2

mitoimmune.com LinkedIn

Mitoimmune Therapeutics Inc. Overview

Headquarters: Seoul, Seoul-teukbyeolsi, Kr
Website: mitoimmune.com
Industry: Biotechnology Research
Employees: 6
Founded: 2018
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Intervene Immune

About Mitoimmune Therapeutics Inc.

MitoImmune is a clinical stage biotech company that focuses on developing drugs for diseases in high unmet needs using mitochondria / ferroptosis based approaches. Our molecules based on the MIT platform are basically mitochondria-targeted ferroptosis inhibitors which have been demonstrated to recover intracellular homeostasis of iron, calcium, redox, and immune and to preserve antioxidant systems such as GPX4 under pathological conditions where an abnormal increase of mitochondrial reactive oxygen species (ROS) and the accumulation of calcium and iron accumulation occur.

Mitoimmune Therapeutics Inc. Contact Details

People in AeroLeads: 3
With contact data: 2
Email contacts: 2; 66.7% coverage

Mitoimmune Therapeutics Inc. Org Chart

Sample employees and titles

Name	Title	Location	Contact
Young Mee Lee	Senior Director, Business Development	South Korea, Korea, Republic of	Email
Sangkweon Jeon	Director / 이사 at Mitoimmune Therapeutics	South Korea, Korea, Republic of	Email
Soonha Kim	Mitoimmune Therapeutics Chief Executive	Seongbuk District, Seoul, South Korea, Korea, Republic of	View